Effects of whole body vibration and core exercise on muscle soreness and performance during a foot march
ISRCTN | ISRCTN12264516 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN12264516 |
- Submission date
- 15/10/2020
- Registration date
- 16/10/2020
- Last edited
- 17/11/2023
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Musculoskeletal Diseases
Plain English summary of protocol
Background and study aims:
Approximately 25% of injuries to United States Infantry and Initial Entry Training (IET) soldiers are due to foot marches, an important military task. Back injuries are one of the most common musculoskeletal injuries resulting from foot marching, accounting for 27% of all foot march injuries. The aim of this study is to evaluate the effect of Core Exercise and Whole Body Vibration on low back pain and performance during a foot march.
Who can participate?
Healthy volunteers aged 19-35 years.
What does the study involve?
Participants will be asked to complete two 8 km foot marches carrying a 35 lbs rucksack, four weeks apart. Participants in the core exercise and whole body vibration with core exercise groups will be asked to complete core exercises three times a week for three week between foot marches. Before, during, after, 1 day and 2 days after completing the foot march low back pain/soreness, performance, muscle oxygenation, .biomarkers via blood draws, muscle activation, posture and exertional levels will be measured.
What are the possible benefits and risks of participating?
There are no direct benefits to the participants. The risk of participating include risk of falling or injury from the whole body vibration platform, risk of dizziness, nausea, headache or vomiting from the whole body vibration platform, risk of pain, redness, swelling, infection, bruising and fainting from the blood draw, risk of muscle soreness, pain or injury from completing the foot march, risk of breach of confidentiality, and a risk of a rash from the adhesive material used to attached EMG sensors to the skin.
Where is the study run from?
Auburn University (USA)
When is the study starting and how long is it expected to run for?
From June 2019 to December 2019
Who is funding the study?
Warrior Research Center (USA)
Who is the main contact?
Kaitlin Lyons
kdm0031@auburn.edu
Contact information
Scientific
301 Wire Road
Auburn
36849
United States of America
0000-0001-9579-1498 | |
Phone | +1 334-844-4483 |
kdm0031@auburn.edu |
Study information
Study design | Single-centre randomized controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Other |
Study type | Prevention |
Participant information sheet | No participant information sheet available |
Scientific title | Effects of a whole body vibration and core exercise intervention on muscle soreness and performance during a foot march: a randomized controlled trial |
Study objectives | Core exercises and whole body vibration is superior to increasing performance and reducing muscle soreness following a foot march |
Ethics approval(s) | Approved 14/07/2019, Auburn University Institutional Review Board (115 Ramsay Hall, Auburn, AL 36849; IRBADMIN@auburn.edu; +1 334-844-5966), ref: 19-211 |
Health condition(s) or problem(s) studied | Low back pain |
Intervention | Study volunteers will be randomly allocated by the researchers, using a random number generator, into one of three groups: 1. Whole body vibration with core exercise 2. Core exercise only 3. Control group. All participants will be asked to complete an 8 km foot march. Following the completion of the foot march and a one week wash-out period, participants in the whole body vibration with exercise and core exercise groups will complete three weeks of core exercise training with or without whole body vibration. Core exercise training with or without whole body vibration will occur for 20 mins, three times per week. The control group will continue with their normal activity. Following three weeks of training, all participants will be asked to complete a second 8 km foot march. During the foot march participants will be asked to carry a 35 lb military rucksack, packed by an Army Officer, as fast as they can safely complete the 8 km distance. Before, during, and after each foot march participant's low back pain/soreness, posture, muscle oxygenation, muscle activation, exertion level, blood biomarkers for muscle soreness/damage and performance will be assessed. Demographic information including age, height, and weight will also be collected using a questionnaire. |
Intervention type | Behavioural |
Primary outcome measure | 1. Low back pain measured using a visual analog scale before, half-way through, immediately after, and 1 day and 2 days following each foot march at 0 and 3 weeks 2. Low back soreness measured using an algometer before, immediately after, and 1 day and 2 days following each foot march at 0 and 3 weeks |
Secondary outcome measures | 1. Performance measured as time to complete the 8 km distance measured at the completion of the foot march at 0 and 3 weeks 2. Muscle Damage measured from blood draws taken before, half-way through, immediately after, and 1 day and 2 days following each foot march at 0 and 3 weeks 3. Muscle Activation measured with surface electromyography (EMG) sensors during the foot march at 0 and 3 weeks 4. Exertion Level measured with Borg rating of perceived exertion scal before, half-way through, immediately after, and 1 day and 2 days following each foot march at 0 and 3 weeks 5. Muscle Oxygenation measured with Humon Hex device (worn on the upper thigh), before, half-way through, immediately after, and 1 day and 2 days following each foot march at 0 and 3 weeks 6. Posture measured with a Zephyr Bioharness (worn around the chest), before, half-way through, immediately after, and 1 day and 2 days following each foot march at 0 and 3 weeks |
Overall study start date | 01/06/2019 |
Completion date | 31/12/2019 |
Eligibility
Participant type(s) | Healthy volunteer |
---|---|
Age group | Adult |
Sex | Both |
Target number of participants | 36 |
Key inclusion criteria | 1. Aged 19-35 years |
Key exclusion criteria | 1. Acute inflammation and infections 2. Acute joint disorders or arthroses 3. Chronic migraine headaches 4. Cardiovascular diseases, such as heart and vascular 5. Recent joint implants such as foot, knee, and implants 6. Heart rhythms or valve disorders 7. Recently placed metal or synthetic implants such as pacemakers and cochlear implants 8. Pregnancy, gallstones, or epilepsy 9. Recent thrombosis or possible thrombotic complaints 10. Tumors, diabetes, or kidney stones 12. Have a current concussion or a concussion within the last 90 days 13. Allergic to adhesives |
Date of first enrolment | 15/07/2019 |
Date of final enrolment | 30/11/2019 |
Locations
Countries of recruitment
- United States of America
Study participating centre
Auburn
36849
United States of America
Sponsor information
University/education
115 Ramsay Hall
Auburn
36849
United States of America
Phone | +1 3348445966 |
---|---|
irbadmin@auburn.edu | |
Website | http://www.auburn.edu/ |
https://ror.org/02v80fc35 |
Funders
Funder type
University/education
No information available
Results and Publications
Intention to publish date | 31/12/2020 |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Data sharing statement to be made available at a later date |
Publication and dissemination plan | Planned publication in a high-impact peer-reviewed journal |
IPD sharing plan | The data sharing plans for the current study are unknown and will be made available at a later date |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | 07/05/2021 | 17/11/2023 | Yes | No |
Editorial Notes
17/11/2023: Publication reference added.
16/10/2020: Trial’s existence confirmed by Auburn University IRB.